- Home
- NIKI vs SCNI Comparison
NIKI vs SCNI Comparison
Compare NIKI & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NIKI | SCNI |
|---|---|---|
| Founded | 2010 | 2003 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5M | 1.2M |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NIKI | SCNI |
|---|---|---|
| Price | $1.87 | $0.54 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.7K | ★ 1.1M |
| Earning Date | 11-10-2026 | 08-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $48.88 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.78 | $0.21 |
| 52 Week High | $10.39 | $3.58 |
Technical Indicators
Market Signals| Indicator | NIKI | SCNI |
|---|---|---|
| Relative Strength Index (RSI) | 22.57 | 28.86 |
| Support Level | N/A | $0.47 |
| Resistance Level | $5.17 | $1.03 |
| Average True Range (ATR) | 0.35 | 0.13 |
| MACD | 0.05 | -0.02 |
| Stochastic Oscillator | 8.54 | 1.81 |
Price Performance
Historical ComparisonAbout NIKI Niki BioSolutions Inc. Common Stock
Niki BioSolutions Inc is a clinical-stage life sciences company focused on unmet medical needs and providing genomic and biomarker testing solutions to healthcare providers, research institutions, and life sciences organizations. Its activities include the development and application of proprietary technologies to support precision medicine across therapeutic areas including brain health and oncology. The company also collaborates with academic centers, disease foundations, and biopharmaceutical companies.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.